Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for myocardial protection in STEMI undergoing primary PCI
ACTRN12618000467235Phase 4Completed
- Sponsor
- The Alfred Hospital
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in myocardial infarction (MI) and acute ST-segment elevation myocardial infarction (STEMI) comparing Doxycycline plus standard of care with Placebo plus standard of care (2 arms). Primary endpoint: Myocardial infarct size. Started Jul 2018; status: completed.
02
Drugs
doxycycline
03
Conditions
myocardial infarction (MI)acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on ACTRN12618000467235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000467235.